| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 7.25e-07 | 7 | 56 | 3 | GO:0004711 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase activity | 3.06e-06 | 36 | 56 | 4 | GO:0015035 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 6.31e-06 | 43 | 56 | 4 | GO:0015036 | |
| GeneOntologyMolecularFunction | histidine-tRNA ligase activity | 7.73e-06 | 2 | 56 | 2 | GO:0004821 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 1.96e-05 | 57 | 56 | 4 | GO:0016667 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 6.68e-05 | 363 | 56 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.39e-04 | 446 | 56 | 7 | GO:0004674 | |
| GeneOntologyMolecularFunction | FAD binding | 2.55e-04 | 44 | 56 | 3 | GO:0071949 | |
| GeneOntologyMolecularFunction | G protein activity | 6.08e-04 | 59 | 56 | 3 | GO:0003925 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 6.35e-04 | 247 | 56 | 5 | GO:0000287 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 7.65e-04 | 709 | 56 | 8 | GO:0016773 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 1.02e-03 | 17 | 56 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CDC42BPA RPS6KA5 RPS6KA2 RPS6KA3 RPS6KA6 PRKCD DMPK G6PC1 PIGO | 1.11e-03 | 938 | 56 | 9 | GO:0016772 |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.26e-03 | 766 | 56 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.38e-03 | 600 | 56 | 7 | GO:0004672 | |
| GeneOntologyMolecularFunction | myosin V binding | 1.42e-03 | 20 | 56 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 1.72e-03 | 22 | 56 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 1.72e-03 | 22 | 56 | 2 | GO:0003756 | |
| GeneOntologyMolecularFunction | myosin binding | 1.75e-03 | 85 | 56 | 3 | GO:0017022 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.81e-03 | 86 | 56 | 3 | GO:0004197 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 2.34e-03 | 94 | 56 | 3 | GO:0050660 | |
| GeneOntologyMolecularFunction | GDP binding | 3.03e-03 | 103 | 56 | 3 | GO:0019003 | |
| GeneOntologyMolecularFunction | kinase activity | 5.31e-03 | 764 | 56 | 7 | GO:0016301 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 5.73e-03 | 775 | 56 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 6.19e-03 | 42 | 56 | 2 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 6.19e-03 | 42 | 56 | 2 | GO:0004812 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 6.48e-03 | 43 | 56 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 8.72e-03 | 839 | 56 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 8.77e-03 | 840 | 56 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 8.77e-03 | 840 | 56 | 7 | GO:0016818 | |
| GeneOntologyBiologicalProcess | histidyl-tRNA aminoacylation | 6.98e-06 | 2 | 55 | 2 | GO:0006427 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.66e-05 | 307 | 55 | 7 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 2.13e-05 | 319 | 55 | 7 | GO:0018209 | |
| GeneOntologyBiologicalProcess | intracellular transport | RAB10 MALT1 ABCA2 DNAJC13 CDC42BPA RAB8B MYO19 ASPH TENM1 PRKCD CD81 RAB1B BBS12 RAB8A | 2.71e-05 | 1496 | 55 | 14 | GO:0046907 |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 1.04e-04 | 410 | 55 | 7 | GO:0006644 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 1.24e-04 | 422 | 55 | 7 | GO:1990778 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid metabolic process | 1.65e-04 | 40 | 55 | 3 | GO:1903725 | |
| GeneOntologyBiologicalProcess | regulation of intracellular transport | 1.84e-04 | 314 | 55 | 6 | GO:0032386 | |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 2.11e-05 | 3 | 56 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 7.25e-05 | 83 | 56 | 4 | GO:0030670 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.31e-04 | 112 | 56 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.57e-04 | 212 | 56 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 5.39e-04 | 13 | 56 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 7.81e-04 | 934 | 56 | 9 | GO:0048471 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 8.30e-04 | 157 | 56 | 4 | GO:0045335 | |
| GeneOntologyCellularComponent | endosome membrane | 1.08e-03 | 602 | 56 | 7 | GO:0010008 | |
| MousePheno | absent Z line | 3.46e-05 | 3 | 48 | 2 | MP:0004092 | |
| MousePheno | abnormal primitive streak formation | 4.65e-05 | 116 | 48 | 5 | MP:0002230 | |
| Domain | Pkinase_C | 3.67e-11 | 42 | 56 | 7 | PF00433 | |
| Domain | AGC-kinase_C | 3.06e-10 | 56 | 56 | 7 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.06e-10 | 56 | 56 | 7 | PS51285 | |
| Domain | S_TK_X | 3.06e-10 | 56 | 56 | 7 | SM00133 | |
| Domain | Ribosomal_S6_kinase_II | 1.08e-09 | 6 | 56 | 4 | IPR016239 | |
| Domain | Pkinase_C | 1.19e-09 | 37 | 56 | 6 | IPR017892 | |
| Domain | His-tRNA-ligase | 8.83e-06 | 2 | 56 | 2 | IPR015807 | |
| Domain | HisRS_anticodon | 8.83e-06 | 2 | 56 | 2 | IPR033656 | |
| Domain | HisRS/HisZ | 8.83e-06 | 2 | 56 | 2 | IPR004516 | |
| Domain | Myotonic_dystrophy_kinase_coil | 5.28e-05 | 4 | 56 | 2 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 5.28e-05 | 4 | 56 | 2 | PD011252 | |
| Domain | DMPK_coil | 5.28e-05 | 4 | 56 | 2 | PF08826 | |
| Domain | RAB | 6.76e-05 | 73 | 56 | 4 | PS51419 | |
| Domain | Ser/Thr_kinase_AS | 9.11e-05 | 357 | 56 | 7 | IPR008271 | |
| Domain | S_TKc | 9.44e-05 | 359 | 56 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 9.94e-05 | 362 | 56 | 7 | PS00108 | |
| Domain | Protein_kinase_ATP_BS | 1.32e-04 | 379 | 56 | 7 | IPR017441 | |
| Domain | Pkinase | 1.36e-04 | 381 | 56 | 7 | PF00069 | |
| Domain | HGTP_anticodon | 3.14e-04 | 9 | 56 | 2 | PF03129 | |
| Domain | PROTEIN_KINASE_ATP | 4.24e-04 | 459 | 56 | 7 | PS00107 | |
| Domain | aa-tRNA-synt_IIb | 4.77e-04 | 11 | 56 | 2 | IPR002314 | |
| Domain | tRNA-synt_2b | 4.77e-04 | 11 | 56 | 2 | PF00587 | |
| Domain | - | 4.77e-04 | 11 | 56 | 2 | 3.40.50.800 | |
| Domain | Calpain_III | 5.72e-04 | 12 | 56 | 2 | IPR022683 | |
| Domain | calpain_III | 5.72e-04 | 12 | 56 | 2 | SM00720 | |
| Domain | C2_III | 5.72e-04 | 12 | 56 | 2 | IPR033883 | |
| Domain | Prot_kinase_dom | 6.18e-04 | 489 | 56 | 7 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 6.48e-04 | 493 | 56 | 7 | PS50011 | |
| Domain | Calpain_domain_III | 6.74e-04 | 13 | 56 | 2 | IPR022682 | |
| Domain | Calpain_III | 6.74e-04 | 13 | 56 | 2 | PF01067 | |
| Domain | Ras | 7.37e-04 | 136 | 56 | 4 | PF00071 | |
| Domain | EGF_extracell | 7.74e-04 | 60 | 56 | 3 | IPR013111 | |
| Domain | EGF_2 | 7.74e-04 | 60 | 56 | 3 | PF07974 | |
| Domain | Calpain_cysteine_protease | 7.85e-04 | 14 | 56 | 2 | IPR022684 | |
| Domain | Anticodon-bd | 7.85e-04 | 14 | 56 | 2 | IPR004154 | |
| Domain | CysPc | 9.04e-04 | 15 | 56 | 2 | SM00230 | |
| Domain | Peptidase_C2_calpain_cat | 9.04e-04 | 15 | 56 | 2 | IPR001300 | |
| Domain | Peptidase_C2 | 9.04e-04 | 15 | 56 | 2 | PF00648 | |
| Domain | CALPAIN_CAT | 9.04e-04 | 15 | 56 | 2 | PS50203 | |
| Domain | Kinase-like_dom | 1.13e-03 | 542 | 56 | 7 | IPR011009 | |
| Domain | aa-tRNA-synth_II | 1.31e-03 | 18 | 56 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 1.31e-03 | 18 | 56 | 2 | PS50862 | |
| Domain | Small_GTPase | 1.35e-03 | 160 | 56 | 4 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 1.58e-03 | 167 | 56 | 4 | IPR005225 | |
| Domain | FA58C | 1.79e-03 | 21 | 56 | 2 | SM00231 | |
| Domain | FA58C_3 | 1.79e-03 | 21 | 56 | 2 | PS50022 | |
| Domain | FA58C_1 | 1.79e-03 | 21 | 56 | 2 | PS01285 | |
| Domain | FA58C_2 | 1.79e-03 | 21 | 56 | 2 | PS01286 | |
| Domain | F5_F8_type_C | 2.34e-03 | 24 | 56 | 2 | PF00754 | |
| Domain | FA58C | 2.34e-03 | 24 | 56 | 2 | IPR000421 | |
| Domain | THIOL_PROTEASE_CYS | 2.74e-03 | 26 | 56 | 2 | PS00139 | |
| Domain | Galactose-bd-like | 2.82e-03 | 94 | 56 | 3 | IPR008979 | |
| Domain | THIOL_PROTEASE_ASN | 2.95e-03 | 27 | 56 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 2.95e-03 | 27 | 56 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 3.17e-03 | 28 | 56 | 2 | IPR000169 | |
| Domain | EGF_LAM_2 | 3.64e-03 | 30 | 56 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 3.64e-03 | 30 | 56 | 2 | PS01248 | |
| Domain | Thioredoxin | 3.88e-03 | 31 | 56 | 2 | PF00085 | |
| Domain | Laminin_EGF | 4.93e-03 | 35 | 56 | 2 | PF00053 | |
| Domain | EGF_Lam | 4.93e-03 | 35 | 56 | 2 | SM00180 | |
| Domain | EGF | 5.38e-03 | 235 | 56 | 4 | SM00181 | |
| Domain | Laminin_EGF | 5.79e-03 | 38 | 56 | 2 | IPR002049 | |
| Domain | - | 5.86e-03 | 122 | 56 | 3 | 3.40.30.10 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 3.69e-07 | 5 | 48 | 3 | MM15108 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 7.36e-07 | 6 | 48 | 3 | M47936 | |
| Pathway | REACTOME_RSK_ACTIVATION | 1.28e-06 | 7 | 48 | 3 | M27369 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 1.28e-06 | 7 | 48 | 3 | M27096 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 1.28e-06 | 7 | 48 | 3 | MM14784 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.64e-05 | 15 | 48 | 3 | MM15103 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 2.24e-05 | 49 | 48 | 4 | M891 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 3.46e-05 | 19 | 48 | 3 | MM14780 | |
| Pathway | REACTOME_ERK_MAPK_TARGETS | 5.45e-05 | 22 | 48 | 3 | M13408 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 6.63e-05 | 126 | 48 | 5 | M16763 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 6.88e-05 | 65 | 48 | 4 | M27771 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 6.88e-05 | 65 | 48 | 4 | MM15511 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 8.27e-05 | 132 | 48 | 5 | M39338 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.02e-04 | 27 | 48 | 3 | MM14779 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 1.14e-04 | 28 | 48 | 3 | MM15132 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.14e-04 | 28 | 48 | 3 | M837 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 1.56e-04 | 31 | 48 | 3 | M15195 | |
| Pathway | WP_INSULIN_SIGNALING | 2.04e-04 | 160 | 48 | 5 | M39482 | |
| Pathway | WP_INSULIN_SIGNALING | 2.04e-04 | 160 | 48 | 5 | MM15956 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.25e-04 | 35 | 48 | 3 | MM15109 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 2.44e-04 | 90 | 48 | 4 | M27779 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 2.54e-04 | 91 | 48 | 4 | MM15518 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.88e-04 | 94 | 48 | 4 | M2843 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 4.40e-04 | 105 | 48 | 4 | M164 | |
| Pathway | WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS | 5.07e-04 | 46 | 48 | 3 | M39805 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 6.83e-04 | 118 | 48 | 4 | MM15589 | |
| Pathway | KEGG_MTOR_SIGNALING_PATHWAY | 7.28e-04 | 52 | 48 | 3 | M7561 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 7.51e-04 | 121 | 48 | 4 | M872 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 7.74e-04 | 122 | 48 | 4 | M27872 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.14e-04 | 54 | 48 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 8.14e-04 | 54 | 48 | 3 | MM15202 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.05e-03 | 59 | 48 | 3 | MM15128 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 1.16e-03 | 61 | 48 | 3 | M152 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK1_TRKA | 1.27e-03 | 63 | 48 | 3 | MM14714 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.32e-03 | 16 | 48 | 2 | MM15477 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | QSOX1 RAB10 MALT1 DNAJC13 RPS6KA5 RPS6KA2 RPS6KA3 PRKCD CD81 LTA4H | 1.63e-03 | 995 | 48 | 10 | MM14661 |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.68e-03 | 18 | 48 | 2 | M657 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.73e-03 | 70 | 48 | 3 | M3115 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.80e-03 | 71 | 48 | 3 | M27382 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 2.07e-03 | 267 | 48 | 5 | M10792 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 2.11e-03 | 75 | 48 | 3 | MM14652 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.19e-03 | 76 | 48 | 3 | MM1433 | |
| Pathway | WP_EGFEGFR_SIGNALING | 2.21e-03 | 162 | 48 | 4 | M39334 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 2.62e-03 | 81 | 48 | 3 | M13863 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 2.74e-03 | 23 | 48 | 2 | M39382 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 3.01e-03 | 85 | 48 | 3 | M3578 | |
| Pathway | REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE | 3.01e-03 | 85 | 48 | 3 | MM14645 | |
| Pathway | WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS | 3.32e-03 | 88 | 48 | 3 | M39495 | |
| Pubmed | HARS2 CDC42BPA RPS6KA5 PLA2G4B RPS6KA2 RPS6KA3 CAPN2 CAPN6 RPS6KA6 PRKCD HARS1 DMPK | 1.60e-09 | 730 | 56 | 12 | 34857952 | |
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 24213529 | ||
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 24416220 | ||
| Pubmed | The RSK2-RPS6 axis promotes axonal regeneration in the peripheral and central nervous systems. | 3.94e-08 | 5 | 56 | 3 | 37068088 | |
| Pubmed | Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. | 3.94e-08 | 5 | 56 | 3 | 11160957 | |
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 12832467 | ||
| Pubmed | GRAF2, WDR44, and MICAL1 mediate Rab8/10/11-dependent export of E-cadherin, MMP14, and CFTR ΔF508. | 3.30e-07 | 9 | 56 | 3 | 32344433 | |
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 3.83e-07 | 37 | 56 | 4 | 20937701 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | RAB10 DNAJC13 CDC42BPA RAB8B CAPN2 LAMA5 PRKCD CD81 LTA4H NQO2 RAB8A | 5.60e-07 | 1016 | 56 | 11 | 19056867 |
| Pubmed | Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases. | 8.61e-07 | 12 | 56 | 3 | 26824392 | |
| Pubmed | 1.12e-06 | 13 | 56 | 3 | 26833786 | ||
| Pubmed | 1.42e-06 | 14 | 56 | 3 | 9687510 | ||
| Pubmed | Cytoplasmic control of Rab family small GTPases through BAG6. | 1.77e-06 | 15 | 56 | 3 | 30804014 | |
| Pubmed | 2.40e-06 | 58 | 56 | 4 | 11856727 | ||
| Pubmed | RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer. | 2.55e-06 | 2 | 56 | 2 | 23635776 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 21464306 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 7755634 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8406012 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11495723 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1549469 | ||
| Pubmed | 2.65e-06 | 17 | 56 | 3 | 37042948 | ||
| Pubmed | 2.94e-06 | 61 | 56 | 4 | 12578829 | ||
| Pubmed | 3.14e-06 | 62 | 56 | 4 | 11773082 | ||
| Pubmed | 5.72e-06 | 72 | 56 | 4 | 16923123 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 38307024 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 33709453 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 28076793 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 22011575 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 31707148 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 30679314 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 12393804 | ||
| Pubmed | Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase. | 7.63e-06 | 3 | 56 | 2 | 12016217 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 12221131 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 9339374 | ||
| Pubmed | Human rsk isoforms: cloning and characterization of tissue-specific expression. | 7.63e-06 | 3 | 56 | 2 | 8141249 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 26977024 | ||
| Pubmed | Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. | 1.52e-05 | 4 | 56 | 2 | 26471730 | |
| Pubmed | Evidence of STAT1 phosphorylation modulated by MAPKs, MEK1 and MSK1. | 1.52e-05 | 4 | 56 | 2 | 14963018 | |
| Pubmed | Chaperone-assisted production of active human Rab8A GTPase in Escherichia coli. | 1.52e-05 | 4 | 56 | 2 | 19116169 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 7623830 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 9770464 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 21457715 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 31428781 | ||
| Pubmed | p90RSK2 is essential for FLT3-ITD- but dispensable for BCR-ABL-induced myeloid leukemia. | 1.52e-05 | 4 | 56 | 2 | 21527514 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 30398148 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 9030196 | ||
| Pubmed | Expression pattern of the Rsk2, Rsk4 and Pdk1 genes during murine embryogenesis. | 1.52e-05 | 4 | 56 | 2 | 12711546 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 2.16e-05 | 732 | 56 | 8 | 34732716 | |
| Pubmed | 2.37e-05 | 103 | 56 | 4 | 11752456 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 10480933 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 15526037 | ||
| Pubmed | Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2. | 2.54e-05 | 5 | 56 | 2 | 32017888 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 15971998 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 16217014 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 9915826 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 17906627 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 18094055 | ||
| Pubmed | Chromosomal protein HMGN1 modulates histone H3 phosphorylation. | 2.54e-05 | 5 | 56 | 2 | 15327773 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 15867353 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 10635333 | ||
| Pubmed | A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1. | 2.54e-05 | 5 | 56 | 2 | 21378754 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 21384559 | ||
| Pubmed | 2.55e-05 | 215 | 56 | 5 | 36808153 | ||
| Pubmed | 2.93e-05 | 371 | 56 | 6 | 25241761 | ||
| Pubmed | Vav Proteins Are Key Regulators of Card9 Signaling for Innate Antifungal Immunity. | 3.80e-05 | 6 | 56 | 2 | 27926862 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 22528498 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 9343414 | ||
| Pubmed | Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. | 3.80e-05 | 6 | 56 | 2 | 8688081 | |
| Pubmed | Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). | 3.80e-05 | 6 | 56 | 2 | 9872331 | |
| Pubmed | Serine phosphorylation and negative regulation of Stat3 by JNK. | 3.80e-05 | 6 | 56 | 2 | 10521505 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 11297520 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 11175347 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 16626623 | ||
| Pubmed | Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases. | 3.80e-05 | 6 | 56 | 2 | 8939914 | |
| Pubmed | 3.89e-05 | 235 | 56 | 5 | 32614325 | ||
| Pubmed | Regulation of liver growth by glypican 3, CD81, hedgehog, and Hhex. | 5.32e-05 | 7 | 56 | 2 | 23665349 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 26209634 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 10880354 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 11157753 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 29162624 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 12763138 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 9396712 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 6.08e-05 | 621 | 56 | 7 | 22794259 | |
| Pubmed | MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. | 7.09e-05 | 8 | 56 | 2 | 12773393 | |
| Pubmed | Cloning of Rab GTPases expressed in human skeletal muscle: studies in insulin-resistant subjects. | 7.09e-05 | 8 | 56 | 2 | 9918381 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 29125462 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 9473662 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 9829964 | ||
| Pubmed | Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. | 7.09e-05 | 8 | 56 | 2 | 16223362 | |
| Pubmed | Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. | 9.10e-05 | 9 | 56 | 2 | 17512525 | |
| Pubmed | P90 Ribosomal s6 kinase 2 negatively regulates axon growth in motoneurons. | 9.10e-05 | 9 | 56 | 2 | 19555761 | |
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 29229781 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 RAB10 MALT1 DNAJC13 CDC42BPA RPS6KA2 ASPH TMX3 NQO2 NAALADL2 | 1.18e-04 | 1489 | 56 | 10 | 28611215 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 1.21e-04 | 1203 | 56 | 9 | 29180619 | |
| Pubmed | 1.32e-04 | 160 | 56 | 4 | 31678930 | ||
| Pubmed | 1.45e-04 | 164 | 56 | 4 | 32409323 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 1.50e-04 | 499 | 56 | 6 | 22810586 | |
| Pubmed | Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. | 1.66e-04 | 12 | 56 | 2 | 18329369 | |
| Pubmed | Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy. | 1.66e-04 | 12 | 56 | 2 | 24717294 | |
| Pubmed | 1.66e-04 | 12 | 56 | 2 | 12576423 | ||
| Interaction | RABIF interactions | 3.01e-06 | 81 | 56 | 5 | int:RABIF | |
| Interaction | PRRT2 interactions | 3.26e-05 | 220 | 56 | 6 | int:PRRT2 | |
| Interaction | RPS6KB1 interactions | 4.79e-05 | 143 | 56 | 5 | int:RPS6KB1 | |
| Interaction | MICAL1 interactions | 6.88e-05 | 79 | 56 | 4 | int:MICAL1 | |
| Interaction | STRADB interactions | 7.05e-05 | 29 | 56 | 3 | int:STRADB | |
| Interaction | GGA2 interactions | 8.75e-05 | 84 | 56 | 4 | int:GGA2 | |
| Interaction | AKT3 interactions | 9.16e-05 | 85 | 56 | 4 | int:AKT3 | |
| Interaction | RHOB interactions | RAB10 CDC42BPA RAB8B PRKCD CD81 NBEA UBIAD1 SLC39A10 NQO2 RAB8A | 9.36e-05 | 840 | 56 | 10 | int:RHOB |
| Cytoband | 2q32.3 | 9.57e-05 | 12 | 56 | 2 | 2q32.3 | |
| Cytoband | 1q24 | 2.74e-04 | 20 | 56 | 2 | 1q24 | |
| Cytoband | 5q31.3 | 8.96e-04 | 36 | 56 | 2 | 5q31.3 | |
| Cytoband | 11q22.3 | 1.34e-03 | 44 | 56 | 2 | 11q22.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q22 | 7.63e-03 | 107 | 56 | 2 | chr11q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q32 | 8.05e-03 | 110 | 56 | 2 | chr2q32 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 6.70e-09 | 11 | 40 | 4 | 1156 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 1.26e-05 | 65 | 40 | 4 | 388 | |
| GeneFamily | C2 domain containing|Calpains | 4.92e-04 | 15 | 40 | 2 | 975 | |
| GeneFamily | Aminoacyl tRNA synthetases, Class II | 7.97e-04 | 19 | 40 | 2 | 132 | |
| Coexpression | XU_GH1_AUTOCRINE_TARGETS_DN | 8.99e-06 | 131 | 56 | 5 | M16384 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | TTC7A QSOX1 RAB10 SLC9A9 SLC8A1 DNAJC13 PRKCD NQO2 RAB8A STAB1 | 4.98e-05 | 1012 | 56 | 10 | M40868 |
| Coexpression | RAF_UP.V1_UP | 5.79e-05 | 193 | 56 | 5 | M2728 | |
| Coexpression | GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP | 6.23e-05 | 196 | 56 | 5 | M7238 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP | 6.38e-05 | 197 | 56 | 5 | M6278 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 | 6.38e-05 | 197 | 56 | 5 | M12824 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN | 6.69e-05 | 199 | 56 | 5 | M5255 | |
| Coexpression | GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP | 6.69e-05 | 199 | 56 | 5 | M5441 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-06 | 193 | 56 | 5 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.87e-06 | 197 | 56 | 5 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| Drug | Ovta | 3.22e-08 | 14 | 56 | 4 | CID003081047 | |
| Drug | AD 288 | 3.22e-08 | 14 | 56 | 4 | CID000073553 | |
| Drug | R165481 | 5.84e-08 | 16 | 56 | 4 | CID005459348 | |
| Drug | AC1MS9WM | 5.52e-07 | 27 | 56 | 4 | CID003530978 | |
| Drug | K00085 | 5.52e-07 | 27 | 56 | 4 | CID009549283 | |
| Drug | A61603 | 1.27e-06 | 33 | 56 | 4 | CID004038180 | |
| Drug | clotrimazole | 1.39e-06 | 143 | 56 | 6 | CID000002812 | |
| Drug | BI D1870 | 2.29e-06 | 11 | 56 | 3 | ctd:C516541 | |
| Drug | DEAC | 1.02e-05 | 55 | 56 | 4 | CID000007277 | |
| Drug | Les T | 1.30e-05 | 123 | 56 | 5 | CID000003189 | |
| Drug | Kemptide | 1.35e-05 | 124 | 56 | 5 | CID000100074 | |
| Drug | I-Q-S | 4.08e-05 | 156 | 56 | 5 | CID000003540 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 5.22e-05 | 83 | 56 | 4 | CID011968896 | |
| Drug | AC1L1GZB | 5.64e-05 | 167 | 56 | 5 | CID000003908 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 2.45e-08 | 4 | 55 | 3 | DOID:3783 (implicated_via_orthology) | |
| Disease | Dyggve-Melchior-Clausen disease (implicated_via_orthology) | 2.45e-08 | 4 | 55 | 3 | DOID:0111167 (implicated_via_orthology) | |
| Disease | Smith-McCort dysplasia (implicated_via_orthology) | 6.11e-08 | 5 | 55 | 3 | DOID:0060247 (implicated_via_orthology) | |
| Disease | Usher syndrome type 3B (implicated_via_orthology) | 3.41e-06 | 2 | 55 | 2 | DOID:0110842 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease, axonal type 2W (implicated_via_orthology) | 3.41e-06 | 2 | 55 | 2 | DOID:0110162 (implicated_via_orthology) | |
| Disease | Perrault syndrome (implicated_via_orthology) | 2.04e-05 | 4 | 55 | 2 | DOID:0050857 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy (implicated_via_orthology) | 2.04e-05 | 4 | 55 | 2 | DOID:2491 (implicated_via_orthology) | |
| Disease | Myocardial Ischemia | 3.29e-04 | 176 | 55 | 4 | C0151744 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 3.53e-04 | 15 | 55 | 2 | EFO_0010367 | |
| Disease | Common Variable Immunodeficiency | 3.53e-04 | 15 | 55 | 2 | C0009447 | |
| Disease | Disorder of eye | 6.63e-04 | 212 | 55 | 4 | C0015397 | |
| Disease | blood pressure | 7.69e-04 | 22 | 55 | 2 | EFO_0004325 | |
| Disease | stroke outcome severity measurement | 1.27e-03 | 114 | 55 | 3 | EFO_0009603 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FDGIATGYLVLKELG | 581 | Q9UBC3 | |
| LKNDLGVGYLLIGDN | 456 | Q12797 | |
| LYYALKEEKVFLGGG | 526 | Q6ZW61 | |
| DLFSGKLYLIGIAAI | 196 | P60033 | |
| YLLYDDKGVGLGEAL | 431 | Q8IXT5 | |
| YDLLFKLLLIGDSGV | 6 | P61026 | |
| DYLFKLLLIGDSGVG | 6 | Q9H0U4 | |
| DYLFKLLLIGDSGVG | 6 | P61006 | |
| EYLALIFEKGGSYLG | 186 | O00391 | |
| DYLFKLLLIGDSGVG | 6 | Q92930 | |
| AIGIEDKIYILGGDY | 546 | Q8NAB2 | |
| KGFALLFYLEQLLGG | 386 | P09960 | |
| YKFGLEGIAAVLLGS | 191 | O15528 | |
| LGSYGLKDGDIVVLL | 61 | Q8WTU0 | |
| YGGLAFLSLEALEGL | 171 | Q6ZSA7 | |
| DEFLLLLDKGVYGLL | 396 | Q9UDY8 | |
| GKVLLGELKGRGEYF | 361 | Q05655 | |
| EFLGGEVLLYKLDDL | 26 | Q96H55 | |
| GKLYLILDFLRGGDL | 141 | P51812 | |
| LYKGLEAFGGLKLED | 331 | P54868 | |
| LLYGEVGDTLLIIFK | 471 | P00451 | |
| GLGGLDNVEYYDIKL | 491 | Q8IXQ5 | |
| LLKVLGTGAYGKVFL | 51 | O75582 | |
| GKLYLILDFLRGGDV | 146 | Q9UK32 | |
| SLYGQLAGLKELGLL | 311 | P0C869 | |
| GSLVLLYDFGAGLKK | 2996 | O15230 | |
| GVLSIYYLGKKFLGD | 91 | Q8N594 | |
| GFYDSGLLQGKLALL | 131 | P16083 | |
| YVGGDLLTLLSKFGE | 151 | Q09013 | |
| IGFYLLLKGLGVDLL | 221 | P35575 | |
| DGLDYLALGKFFKGL | 1356 | Q8WXX0 | |
| LFLKGTYGDGYRLTL | 1206 | Q9BZC7 | |
| YLLKLLEGIGLENLD | 2136 | O75165 | |
| SDGSGKLGLKEFYIL | 586 | P17655 | |
| AYAKLLGCYEALDGL | 166 | Q9Y6Q1 | |
| LKGLVALGGIYLLFI | 496 | Q9ULF5 | |
| LEGLGDLKLLFEYLT | 296 | P12081 | |
| LLKYFTSDGLPIGDL | 606 | Q96DY7 | |
| ALEGLGDLKLLFEYL | 296 | P49590 | |
| GDLKLLFEYLTLFGI | 301 | P49590 | |
| LGLGGYELKLEQTLG | 626 | Q8IVB4 | |
| LIYKIELAGGLGAIF | 351 | Q9NP60 | |
| LGGKGFLVIGYLLEK | 546 | Q8NFP9 | |
| FSLDKIYLIGGDLGP | 21 | Q9Y248 | |
| GGLYDFLTKLVHLGQ | 2361 | Q9UKZ4 | |
| YYVGGDLLTLLSKFE | 156 | Q5VT25 | |
| GFLLYELGDTGKLVA | 236 | Q96JJ7 | |
| DLPKSYDYDLIIIGG | 156 | Q16881 | |
| VDFILLKYGLVGGEG | 531 | Q92752 | |
| GYKIFSGLLKVAGLL | 1736 | Q9NY15 | |
| KLEHLALIYFGGLSG | 156 | Q9Y5Z9 | |
| EAGEFLPKGYLALGL | 481 | Q9ULT0 | |
| AYAGLLGTIELKLDL | 496 | Q8TEQ8 | |
| EGFLLLLLFGYEATL | 6 | O15537 | |
| EGKLYLILDFLRGGD | 131 | Q15349 | |
| LLNELGGFTITGKYL | 641 | P32418 | |
| SLEKAGFGGVLLYID | 316 | Q58DX5 |